Mancia G
Cattedra di Semeiotica Medica, University of Milan, Italy.
Am Heart J. 1988 Jan;115(1 Pt 2):240-2. doi: 10.1016/0002-8703(88)90643-6.
This symposium deals with the relationship between smoking and increased risk of cardiovascular disease within a number of perspectives ranging from the biochemical to the epidemiologic. The established major risk factors for cardiovascular disease, hypertension, hypercholesterolemia, and smoking, are present, often in combination, in populations around the world. These factors have been found to interact in a synergistic manner to increase the risk of coronary heart disease. Traditional antihypertensive treatment offers little protection against coronary heart disease, perhaps because antihypertensive drugs tend to be prescribed to reduce blood pressure without attention being paid to the presence of other risk factors. This symposium should clarify new knowledge on cardiovascular risk factors, thus influencing future therapeutic strategies for hypertension and cardiovascular disease in patients who smoke.
本次研讨会从生物化学到流行病学等多个角度探讨了吸烟与心血管疾病风险增加之间的关系。心血管疾病已确定的主要危险因素,即高血压、高胆固醇血症和吸烟,常常同时出现在世界各地的人群中。人们发现这些因素会以协同方式相互作用,增加冠心病风险。传统的抗高血压治疗对冠心病几乎没有保护作用,这可能是因为抗高血压药物往往只是为了降低血压而开具,却没有关注其他危险因素的存在。本次研讨会应能阐明有关心血管危险因素的新知识,从而影响未来对吸烟患者高血压和心血管疾病的治疗策略。